genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Danaher
Bioprocessing
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform
Artificial Intelligence
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
Genome Editing
Danaher Partners with IGI, Doudna, & Urnov, on Beacon for CRISPR Cures
Bioprocessing
StockWatch: Danaher, Thermo Fisher Revenue Declines Rattle Analysts
Drug Discovery
Meeting on the Mesa: Biotech Investing Deal Makers and Breakers
Drug Discovery
StockWatch: Abcam Founder Opposes $5.7B Danaher Acquisition
Drug Discovery
Danaher to Acquire Abcam for $5.7B
Drug Discovery
StockWatch: Catalent Cuts Revenue, EBITDA Forecasts, Rattling Investors
News
Napo Pulls the Plug on Partnership with Salix for Diarrhea Drug
Scroll Up
Scroll Up
